Skip to content

A comparison assessment of efficacy of Vamana karma with Madana Phala Vs Ikshwaku in Poly Cystic Ovarian Syndrome

OPEN LABEL RANDOMISED CLINICAL STUDY TO COMPARE THE EFFICACY OF VAMANA KARMA WITH MADANA PHALA VS IKSHKHWAKU IN POLY CYSTIC OVARIAN SYNDROME - PCOS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021888
Enrollment
30
Registered
2019-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Madanphal and Ikshwaku: Churna of the drug will be administer to the selected patient of PCOS to see the efficacy of Madanphala and Ikshkhwaku Intervention2: Madanphala Churna: Vamana (

Sponsors

Mandsaur Institute of Ayurveda Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASHRM/ESHRE(ROTTERDAM) CRITERIA 2003 Affected individual must have two out of three criteria Oligo or anovulation Hyperandrogenesim clinical or biochemical Polycystic ovaries on sonographic examination Clinically diagnosed and confirmed patients of PCOS

Exclusion criteria

Exclusion criteria: Women of age less than 18 and above than 40 years. Patient having systemic disease like hypertension, tuberculosis, renal disease etc. Patient having menometrorrhagia with poly cystic overies Patient having congenital adrenal hyperplasia androgen secreting tumours HIV VDRL HBsAg positive patient

Design outcomes

Primary

MeasureTime frame
To prove the efficacy of Vamana with Ikshwaku in treatment of PCOS Timepoint: With in Three years

Secondary

MeasureTime frame
Identifying the best drug to conduct Vamana in case of PCOSTimepoint: With in Three years

Countries

India

Contacts

Public ContactDr Siba Prasad

Mandsaur Institute of Ayurveda Education and Research

dr.rpmishra@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026